Standout Papers
Citation Impact
Citing Papers
Concurrent Radiotherapy and Ipilimumab Immunotherapy for Patients with Melanoma
2013
Stereotactic Radiation Therapy Augments Antigen-Specific PD-1–Mediated Antitumor Immune Responses via Cross-Presentation of Tumor Antigen
2014
Tumor-reactive CD4+ T cells develop cytotoxic activity and eradicate large established melanoma after transfer into lymphopenic hosts
2010 StandoutNobel
TGFβ Is a Master Regulator of Radiation Therapy-Induced Antitumor Immunity
2015
Potent Induction of Tumor Immunity by Combining Tumor Cryoablation with Anti–CTLA-4 Therapy
2011 StandoutNobel
Blockade of CTLA-4 on both effector and regulatory T cell compartments contributes to the antitumor activity of anti–CTLA-4 antibodies
2009 StandoutNobel
Fc-dependent depletion of tumor-infiltrating regulatory T cells co-defines the efficacy of anti–CTLA-4 therapy against melanoma
2013 StandoutNobel
Synergy of Topical Toll-like Receptor 7 Agonist with Radiation and Low-Dose Cyclophosphamide in a Mouse Model of Cutaneous Breast Cancer
2012
Radiotherapy Increases the Permissiveness of Established Mammary Tumors to Rejection by Immunomodulatory Antibodies
2012
Radiation-Induced CXCL16 Release by Breast Cancer Cells Attracts Effector T Cells
2008
mRNA-based vaccines synergize with radiation therapy to eradicate established tumors
2014
Modulation of radiochemoimmunotherapy-induced B16 melanoma cell death by the pan-caspase inhibitor zVAD-fmk induces anti-tumor immunity in a HMGB1-, nucleotide- and T-cell-dependent manner
2015
Systemic effects of local radiotherapy
2009
Cancer Invasion and the Microenvironment: Plasticity and Reciprocity
2011 Standout
Radiation-Induced Vascular Damage in Tumors: Implications of Vascular Damage in Ablative Hypofractionated Radiotherapy (SBRT and SRS)
2012
Elements of cancer immunity and the cancer–immune set point
2017 StandoutNature
Abscopal effect of radiation on lung metastases of hepatocellular carcinoma: a case report
2011
Targeting cytotoxic T‐lymphocyte antigen‐4 (CTLA‐4)
2007
Oncology Meets Immunology: The Cancer-Immunity Cycle
2013 Standout
A concomitant ATP-depleting strategy markedly enhances anticancer agent activity
2001
Radiotherapy augments the immune response to prostate cancer in a time‐dependent manner
2008
Role of Radiation-induced TGF-beta Signaling in Cancer Therapy
2009
mRNA vaccines — a new era in vaccinology
2018 StandoutNobel
Ipilimumab alone or in combination with radiotherapy in metastatic castration-resistant prostate cancer: results from an open-label, multicenter phase I/II study
2013
CTLA-4 blockade synergizes with cryoablation to mediate tumor rejection
2012 StandoutNobel
Combining Radiotherapy and Cancer Immunotherapy: A Paradigm Shift
2013
Current Clinical Trials Testing Combinations of Immunotherapy and Radiation
2014
The tumour microenvironment after radiotherapy: mechanisms of resistance and recurrence
2015 Standout
Adjuvant Therapy With Agonistic Antibodies to CD134 (OX40) Increases Local Control After Surgical or Radiation Therapy of Cancer in Mice
2010
Combined local immunostimulatory radioisotope therapy and systemic immune checkpoint blockade imparts potent antitumour responses
2018
Principles and use of anti-CTLA4 antibody in human cancer immunotherapy
2006 StandoutNobel
The Abscopal Effect Associated With a Systemic Anti-melanoma Immune Response
2013
Immunogenic cell death in cancer and infectious disease
2016 Standout
Soft-Tissue Sarcomas in Adults
2005 Standout
Immunostimulatory monoclonal antibodies for cancer therapy
2007
MPDL3280A (anti-PD-L1) treatment leads to clinical activity in metastatic bladder cancer
2014 StandoutNature
Biological Functions of Autophagy Genes: A Disease Perspective
2019 Standout
Radiotherapy and Toll-Like Receptor Agonists
2014
Evolving synergistic combinations of targeted immunotherapies to combat cancer
2015
Lung cancer: current therapies and new targeted treatments
2016 Standout
Intratumoral modulation of the inducible co-stimulator ICOS by recombinant oncolytic virus promotes systemic anti-tumour immunity
2017 StandoutNobel
Immune Checkpoint Targeting in Cancer Therapy: Toward Combination Strategies with Curative Potential
2015 StandoutNobel
Immune-mediated mechanisms influencing the efficacy of anticancer therapies
2015
PD-1 and PD-L1 Immune Checkpoint Blockade to Treat Breast Cancer
2016 Standout
Combining radiotherapy and immunotherapy: A revived partnership
2005
Radiation as Immunomodulator: Implications for Dendritic Cell-Based Immunotherapy
2014
Immune checkpoint modulation: Rational design of combination strategies
2015
Current clinical trials testing the combination of immunotherapy with radiotherapy
2016
Fibrosis of two: Epithelial cell-fibroblast interactions in pulmonary fibrosis
2013
Potential role of magnetic resonance spectroscopy in assessment of tumour response in childhood cancer
2003
Apoptosis induced in advanced CD8F1-murine mammary tumors by the combination of PALA, MMPR and 6AN precedes tumor regression and is preceded by ATP depletion
1997
Primary, Adaptive, and Acquired Resistance to Cancer Immunotherapy
2017 Standout
Radiotherapy: Changing the Game in Immunotherapy
2016
Checkpoint Blockade in Cancer Immunotherapy
2006 StandoutNobel
Microbiota: a key orchestrator of cancer therapy
2017
Radiation fosters dose-dependent and chemotherapy-induced immunogenic cell death
2014
Radiation for Awakening the Dormant Immune System, a Promising Challenge to be Explored
2014
In situ vaccination by radiotherapy to improve responses to anti-CTLA-4 treatment
2015
Studies of human tumors by MRS: A review
1992
Imatinib potentiates antitumor T cell responses in gastrointestinal stromal tumor through the inhibition of Ido
2011 StandoutNobel
Renal cell carcinoma
2017 Standout
VEGF in Signaling and Disease: Beyond Discovery and Development
2019 Standout
Combination immunotherapy: a road map
2017
Abscopal effects of radiotherapy on advanced melanoma patients who progressed after ipilimumab immunotherapy
2014
The Tumor-Immune Microenvironment and Response to Radiation Therapy
2010
Antitumor Immunity Induced after α Irradiation
2014
Principles of Cancer Therapy: Oncogene and Non-oncogene Addiction
2009 Standout
Atezolizumab for First-Line Treatment of Metastatic Nonsquamous NSCLC
2018 Standout
Biochemical Modulation of Cisplatin Mechanisms of Action: Enhancement of Antitumor Activity and Circumvention of Drug Resistance
2003 Standout
TGFβ1 Inhibition Increases the Radiosensitivity of Breast Cancer CellsIn Vitroand Promotes Tumor Control by RadiationIn Vivo
2011
Coinhibitory Pathways in Immunotherapy for Cancer
2016
An Abscopal Response to Radiation and Ipilimumab in a Patient with Metastatic Non–Small Cell Lung Cancer
2013
Fractionated but Not Single-Dose Radiotherapy Induces an Immune-Mediated Abscopal Effect when Combined with Anti–CTLA-4 Antibody
2009
Cancer Immunoediting: Integrating Immunity’s Roles in Cancer Suppression and Promotion
2011 StandoutScience
Limited tumor infiltration by activated T effector cells restricts the therapeutic activity of regulatory T cell depletion against established melanoma
2008 StandoutNobel
Cell intrinsic mechanisms of T‐cell inhibition and application to cancer therapy
2008 StandoutNobel
Fundamental Mechanisms of Immune Checkpoint Blockade Therapy
2018 StandoutNobel
Immunologic and clinical effects of antibody blockade of cytotoxic T lymphocyte-associated antigen 4 in previously vaccinated cancer patients
2008 StandoutNobel
Spermidine in health and disease
2018 StandoutScience
Chemotherapy induces enrichment of CD47 + /CD73 + /PDL1 + immune evasive triple-negative breast cancer cells
2018 StandoutNobel
Combining Radiation and Immunotherapy: A New Systemic Therapy for Solid Tumors?
2014 StandoutNobel
The Mechanism of Anti-CTLA-4 Activity and the Negative Regulation of T-Cell Activation
2008
Chimeric Antigen Receptor Therapy
2018 Standout
Phase 1 Study of Stereotactic Body Radiotherapy and Interleukin-2—Tumor and Immunological Responses
2012
The future of immune checkpoint therapy
2015 StandoutScienceNobel
Fibrosis — A Common Pathway to Organ Injury and Failure
2015 Standout
Radiotherapy combination opportunities leveraging immunity for the next oncology practice
2016
B7-H3 and B7x are highly expressed in human prostate cancer and associated with disease spread and poor outcome
2007 StandoutNobel
ATP depletion + pyrimidine depletion can markedly enhance cancer therapy: fresh insight for a new approach.
2000
Precision glycocalyx editing as a strategy for cancer immunotherapy
2016 StandoutNobel
Reactive Oxygen Species (ROS)-Based Nanomedicine
2019 Standout
Prognostic Significance of a Novel Hypoxia-Regulated Marker, Carbonic Anhydrase IX, in Invasive Breast Carcinoma
2001 StandoutNobel
Combination therapy strategies for improving PD‐1 blockade efficacy: a new era in cancer immunotherapy
2017 StandoutNobel
PD-1 and CTLA-4 combination blockade expands infiltrating T cells and reduces regulatory T and myeloid cells within B16 melanoma tumors
2010 StandoutNobel
CTLA-4 blockade enhances polyfunctional NY-ESO-1 specific T cell responses in metastatic melanoma patients with clinical benefit
2008 StandoutNobel
A Systemic Complete Response of Metastatic Melanoma to Local Radiation and Immunotherapy
2012
Neoantigens in cancer immunotherapy
2015 StandoutScience
Hypoxia-inducible factor-dependent signaling between triple-negative breast cancer cells and mesenchymal stem cells promotes macrophage recruitment
2014 StandoutNobel
Immune Checkpoint Blockade in Cancer Therapy
2015 Standout
Cancer immunotherapy using checkpoint blockade
2018 StandoutScience
Indoleamine 2,3-dioxygenase is a critical resistance mechanism in antitumor T cell immunotherapy targeting CTLA-4
2013 StandoutNobel
Atezolizumab and Nab-Paclitaxel in Advanced Triple-Negative Breast Cancer
2018 Standout
Integrin–TGF‐β crosstalk in fibrosis, cancer and wound healing
2010
Works of M. Devitt being referenced
Quantitative changes in tumor metabolism, partial pressure of oxygen, and radiobiological oxygenation status postradiation.
1992
Ionizing radiation inhibition of distant untreated tumors (abscopal effect) is immune mediated
2004
Inhibition of Integrin αvβ6, an Activator of Latent Transforming Growth Factor-β, Prevents Radiation-induced Lung Fibrosis
2007
In vivo monitoring of changes in 5‐fluorouracil metabolism induced by methotrexate measured by 19F NMR spectroscopy
1991
Potentiation of a three drug chemotherapy regimen by radiation.
1993
Immune-Mediated Inhibition of Metastases after Treatment with Local Radiation and CTLA-4 Blockade in a Mouse Model of Breast Cancer
2005 StandoutNobel